These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 38101785

  • 1. [Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome].
    Hong LR, Chen YJ, Jiang QL, Jia RL, Li C, Feng LH.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec 18; 55(6):1033-1038. PubMed ID: 38101785
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
    Zhou K, Zhang J, Zheng ZR, Zhou YZ, Zhou X, Wang LD, Suo B, Jiang XF, Liu PJ, Wang DH.
    Clin Appl Thromb Hemost; 2020 Dec 18; 26():1076029620971041. PubMed ID: 33141604
    [Abstract] [Full Text] [Related]

  • 3. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
    Huang K, Mo Q, Liao C, Feng S, Liu G, Jiang D, Lei P.
    Clin Exp Med; 2024 May 22; 24(1):107. PubMed ID: 38776019
    [Abstract] [Full Text] [Related]

  • 4. [Influencing factors of thrombosis besides antiphospholipid antibodies in patients with antiphospholipid syndrome].
    Fan YY, Chen C, Liu HJ, Cai WX, Hou YK, Li C.
    Zhonghua Yi Xue Za Zhi; 2021 Nov 23; 101(43):3588-3593. PubMed ID: 34808753
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
    Wang L, Zhong J, Xiao D, Huang W, Zheng Z, Jiang Y.
    Ann Transl Med; 2022 Dec 23; 10(23):1273. PubMed ID: 36618792
    [Abstract] [Full Text] [Related]

  • 7. Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction.
    Zhao X, Yang S, Lei R, Duan Q, Li J, Meng J, Sun L.
    Front Neurol; 2022 Dec 23; 13():942887. PubMed ID: 36761916
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
    Ren W, Zhang J, Chen Y, Wen M, Su Y, Zhao Y, Lu S, Wu J.
    Clin Appl Thromb Hemost; 2020 Dec 23; 26():1076029620982666. PubMed ID: 33356499
    [Abstract] [Full Text] [Related]

  • 10. Antiphosphatidylserine/prothrombin complex antibodies as a determinant of prothrombotic plasma fibrin clot properties in patients with antiphospholipid syndrome.
    Ząbczyk M, Celińska-Löwenhoff M, Plens K, Iwaniec T, Musiał J, Undas A.
    J Thromb Haemost; 2019 Oct 23; 17(10):1746-1755. PubMed ID: 31220407
    [Abstract] [Full Text] [Related]

  • 11. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 23; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 12. [Value of Coagulation and Fibrinolysis Biomarker in Lung Cancer Patients with Thromboembolism].
    Fu Y, Liu Y, Jin Y, Jiang H.
    Zhongguo Fei Ai Za Zhi; 2018 Aug 20; 21(8):583-587. PubMed ID: 30172264
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Global antiphospholipid syndrome score and anti-ß2-glycoprotein I domain I for thrombotic risk stratification in antiphospholipid syndrome: A four-year prospective study.
    Nascimento IS, Radin M, Gândara APR, Sciascia S, de Andrade DCO.
    Lupus; 2020 Jun 20; 29(7):676-685. PubMed ID: 32279584
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic value of antibodies to phosphatidylserine/prothrombin complex for antiphospholipid syndrome in Chinese patients.
    Zhu L, Li C, Liu N, Yang X, Jia RL, Mu R, Su Y, Li ZG.
    Clin Rheumatol; 2017 Feb 20; 36(2):401-406. PubMed ID: 28050648
    [Abstract] [Full Text] [Related]

  • 17. [The clinical manifestations and thrombotic risk factors in primary antiphospholipid syndrome].
    Zhao JL, Sun YD, Zhang Y, Xu D, Wang Q, Li MT, Zeng XF.
    Zhonghua Nei Ke Za Zhi; 2016 May 01; 55(5):386-91. PubMed ID: 27143190
    [Abstract] [Full Text] [Related]

  • 18. Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer.
    Lirong T, Minmin X, Manqiu Y, Yanping L.
    Hippokratia; 2022 May 01; 26(2):78-82. PubMed ID: 37188051
    [Abstract] [Full Text] [Related]

  • 19. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
    Yang Y, Hu Y, Wu M, Xiang Z.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr 28; 47(4):469-478. PubMed ID: 35545342
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of coagulation markers in patients with colorectal caner: A prospective study.
    Chen W, Li Y, Wang W, Xue Y, Qian J, Liu W, Hu X.
    Health Sci Rep; 2024 Feb 28; 7(2):e1553. PubMed ID: 38304067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.